February 19, 2021
Article
Determining grade of disease is important, as nephron-sparing approaches may be feasible.
February 10, 2021
Article
In this interview, Emmanuel S. Antonarakis, MD, provides an overview of rucaparib (Rubraca) and olaparib (Lynparza), discusses the key trials that led to their approvals, and explains the urologist’s role in their use.
February 09, 2021
Article
"We typically do urodynamics when something’s unclear and confusing. I don’t always do urodynamics before doing a sling," says 1 urologist.
February 05, 2021
Article
"It is essential for us to be vigilant about all the complications, whether local or systemic, associated with intravesical BCG," writes Badar M. Mian, MD.
February 01, 2021
Article
"Unfortunately, we have found that most if not all insurers do not pay for this code and additionally often have policies against charging patients for extra supplies, and balance billing would be a violation of their contract," write Jonathan Rubenstein, MD, and Mark Painter.
January 29, 2021
Article
"I have no problem with patients seeing everything in their chart. It is their medical record, after all. But I do think there should be some limitations on this access," writes Henry Rosevear, MD.
January 29, 2021
Article
The provider said the patient failed to timely return for follow-up.
January 28, 2021
Article
"Here we show that there are clear benefits in delaying radiographic progression or death, [PSA] progression, and other outcomes in the largest groups of men with metastatic hormone-sensitive prostate cancer and lymph node and bone metastases,” says Andrew Armstrong, MD.